DR REDDYS LABORATORIES LTD - ADR (RDY)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / ADR
Shares, excl. options Q2 2024
24.1M
Holdings value Q2 2024
$1.84B
Value change Q2 2024
+$26.1M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
216
Number of buys Q2 2024
111
Number of sells Q2 2024
-98
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 24.1M $1.84B +$26.1M $76.19 217
2024 Q1 23.6M $1.73B +$4.26M $73.35 228
2023 Q4 23.5M $1.64B -$19.9M $69.58 218
2023 Q3 22.5M $1.51B +$123M $66.87 209
2023 Q2 20.7M $1.31B +$123M $63.11 189
2023 Q1 18.8M $1.07B +$136M $56.93 186
2022 Q4 16.4M $850M +$3.22M $51.75 160
2022 Q3 16.3M $857M +$35.9M $52.34 147
2022 Q2 15.7M $866M -$30.4M $55.39 148
2022 Q1 16.6M $924M +$4.92M $55.73 145
2021 Q4 16.5M $1.07B -$47.5M $65.41 142
2021 Q3 17M $1.11B -$93.4M $65.14 144
2021 Q2 18.4M $1.35B +$10.5M $73.51 156
2021 Q1 18.3M $1.13B -$17.3M $61.39 160
2020 Q4 19.1M $1.36B -$154M $71.29 172
2020 Q3 21.3M $1.48B -$17.9M $69.56 185
2020 Q2 21.6M $1.15B +$16.6M $53.01 168
2020 Q1 21.3M $861M -$4.22M $40.33 144
2019 Q4 21.4M $870M +$18.2M $40.58 144
2019 Q3 21M $795M -$26.2M $37.89 149
2019 Q2 21.7M $811M +$17.8M $37.47 147
2019 Q1 21.1M $856M +$30.8M $40.50 142
2018 Q4 20.4M $770M +$59.5M $37.70 144
2018 Q3 18.9M $650M -$44M $34.60 123
2018 Q2 20.3M $654M -$49.6M $32.20 131
2018 Q1 21.8M $711M +$108K $32.69 121
2017 Q4 21.8M $817M -$37.5M $37.56 117
2017 Q3 22.7M $811M -$95.7M $35.68 118
2017 Q2 25.3M $1.07B +$15M $42.14 126
2017 Q1 25M $1B -$47.4M $40.15 131
2016 Q4 27.2M $1.23B +$10.9M $45.28 158
2016 Q3 26.6M $1.23B -$11.2M $46.42 152
2016 Q2 26.8M $1.39B -$10.7M $51.23 153
2016 Q1 26.6M $1.21B -$134M $45.19 154
2015 Q4 28.1M $1.31B -$11.8M $46.29 167
2015 Q3 27.9M $1.78B +$197M $63.91 200
2015 Q2 25M $1.38B +$29.8M $55.32 186
2015 Q1 24.5M $1.4B -$54.9M $57.10 170
2014 Q4 25.5M $1.28B +$45.9M $50.45 163
2014 Q3 24.2M $1.27B -$18.3M $52.55 156
2014 Q2 25.5M $1.1B +$52.7M $43.15 168
2014 Q1 24.3M $1.07B +$98.2M $43.90 165